PTCT Crosses Above Average Analyst Target
September 26, 2016 at 09:57 AM EDT
In recent trading, shares of PTC Therapeutics Inc (PTCT) have crossed above the average analyst 12-month target price of $11.40, changing hands for $11.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..